Alternative Medicines as Emerging Therapies for Inflammatory Bowel Diseases

被引:36
作者
Singh, Udai P. [1 ]
Singh, Narendra P. [1 ]
Busbee, Brandon [1 ]
Guan, H. [1 ]
Singh, Balwan [2 ]
Price, Robert L. [3 ]
Taub, Dennis D. [4 ]
Mishra, Manoj K. [5 ]
Nagarkatti, Mitzi
Nagarkatti, Prakash S.
机构
[1] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA
[2] Emory Univ, Natl Primate Res Ctr, Atlanta, GA 30322 USA
[3] Univ S Carolina, Dept Cell & Dev Biol, Columbia, SC 29208 USA
[4] NIA IRP, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA
[5] Alabama State Univ, Dept Biol & Math Sci, Montgomery, AL 36101 USA
关键词
bromelain; Crohn disease (CD); curcumin; inflammation; inflammatory bowel disease (IBD); polyphenols; pomegranate; resveratrol; rutin; ulcerative colitis (UC); AVIUM SUBSP PARATUBERCULOSIS; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; RICH POMEGRANATE EXTRACT; CHIMERIC MONOCLONAL-ANTIBODY; PEDIATRIC CROHNS-DISEASE; N-3; FATTY-ACIDS; ALOE-VERA GEL; ULCERATIVE-COLITIS; GREEN TEA;
D O I
10.3109/08830185.2011.642909
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammatory bowel disease (IBD) can be divided into two major categories, ulcerative colitis (UC) and Crohn disease (CD). While the main cause(s) of IBD remain unknown, a number of interventional and preventive strategies have been proposed for use against CD and UC. Many reports have focused on the use of alternative natural medicines as potential therapeutic interventions in IBD patients with minimal side effects. While the use of alternative medicines may be effective in IBD patients that are refractory to corticosteroids or thiopurins, alternative treatment strategies are limited and require extensive clinical testing before being optimized for use in patients.
引用
收藏
页码:66 / 84
页数:19
相关论文
共 50 条
[31]   Nutrition and inflammatory bowel diseases: Pathophysiological aspects [J].
Arnone, Djesia ;
Boudaud, Marie ;
Caron, Benedicte ;
Touly, Nina ;
Peyrin-Biroulet, Laurent .
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (08) :1008-1016
[32]   Mucins in inflammatory bowel diseases and colorectal cancer [J].
Sheng, Yong H. ;
Hasnain, Sumaira Z. ;
Florin, Timothy H. J. ;
McGuckin, Michael A. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (01) :28-38
[33]   Diet supporting therapy for inflammatory bowel diseases [J].
Kikut, Justyna ;
Konecka, Nina ;
Zietek, Maciej ;
Kulpa, Danuta ;
Szczuko, Malgorzata .
EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (05) :2275-2291
[34]   Probiotics in Pediatric Gastroenterology Emerging Indications in Inflammatory Bowel Diseases [J].
Scarpato, Elena ;
Russo, Marina ;
Staiano, Annamaria .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 :S7-S9
[35]   Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis [J].
Parian, Alyssa ;
Limketkai, Berkeley N. .
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (02) :180-188
[36]   Etiopathogenesis of inflammatory bowel diseases [J].
Göke, MN .
CHIRURGISCHE GASTROENTEROLOGIE, 2002, 18 (04) :302-307
[37]   Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning [J].
Fudman, David I. ;
Mcconnell, Ryan A. ;
Ha, Christina ;
Singh, Siddharth .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (03) :454-468
[38]   History of Inflammatory Bowel Diseases [J].
Actis, Giovanni Clemente ;
Pellicano, Rinaldo ;
Fagoonee, Sharmila ;
Ribaldone, Davide Giuseppe .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
[39]   Genetics of Inflammatory Bowel Diseases [J].
McGovern, Dermot P. B. ;
Kugathasan, Subra ;
Cho, Judy H. .
GASTROENTEROLOGY, 2015, 149 (05) :1163-+
[40]   Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases [J].
Bunt, Daan, V ;
Minnaard, Adriaan J. ;
El Aidy, Sahar .
PHARMACEUTICALS, 2021, 14 (06)